• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with

Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：tanmite123
【摘 要】
：
Background The common features shared by primary plasma cell leukemia (pPCL) and multiple myeloma (MM) with circulating plasma cells (CPCs) are peripheral blood invasion and expansion of plasma cells
【作 者】
：
Shuhui Deng Gang An Yan Xu Zengjun Li Shuhua Yi Meirong Zang Xiaoyan Feng Juyuan QI Yaozhong Zhao Dehui Zou Jiangxiang Wang Kun Ru Lugui Qiu 
【机 构】
：
Institute of Hematology and Blood Disease Hospital,Chinese Academy of Medical Sciences and Peking
【出 处】
：
The 35th World Congress of the International Society of Hema
【发表日期】
：
2014年5期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background The common features shared by primary plasma cell leukemia (pPCL) and multiple myeloma (MM) with circulating plasma cells (CPCs) are peripheral blood invasion and expansion of plasma cells independent of the protective bone marrow (BM) microenvironment niche.
其他文献
Desialylation level of platelets is elevated in immune thrombocytopenia and decreases among therapeu
Objective To study the desialylation status of platelets in immune thrombocytopenia (ITP) and evaluate its association with anti-platelet autoantibody specificity and patients response to therapies.
会议
Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long
The purpose of this study was to compare the effects of different dosages of intravenous immunoglobulin (IVIg) for treatment of immune thrombocytopenia.A total of 167 eligible patients were included a
会议
The effects of different B-cell activating factor receptors on lymphocyte function and secretion of
Background Immune thrombocytopenia (ITP) is an autoimmune disorder in which the patients immune system is activated by platelet autoantigens resulting in immune-mediated platelet destruction and/or su
会议
The Evaluation Of Efficacy And Safety Of Splenectomy In Adults With Chronic Immune Thrombocytopenic
Background.The spleen in immune thrombocytopenic purpura (ITP) patients is an important source of anti-platelet antibodies and the major site of platelet destruction.Splenectomy is the only treatment
会议
Increased interleukin-27 promotes Th1 differentiation in patients with chronic immune thrombocytopen
Background Chronic immune thrombocytopenia (cITP) is an autoimmune disease with disturbed cytokine profile.Although plasma levels of IL-27 are shown to be associated with cITP,its association with T c
会议
Correction of abnormal IL-12 family cytokines by high-dose dexamethasone in chronic immune thrombocy
The mechanism of cellular immune abnormalities in the patients with chronic immune thrombocytopenia (cITP) remains unclear.The Interleukin (IL)-12 family cytokines consists of IL-12,IL-23,IL-27 and IL
会议
The Effects of Panaxadiol Saponins on Megakaryocytic Maturation and Immune Function in a Mouse Model
We have identified a biological active component,panaxadiol saponins component (PDS-C),fro m Chinese ginseng extract.PDS-C contains 5 ginsenoside monomers with total purity of 92.44 ％.In this study,th
会议
Bruton tyrosine kinase inhibitor on multiple myeloma in vivo
Objective The aim of the study was to learn the mechanism of the Btk inhibitor on MM in vivo.Methods The myeloma cell line U266 was cultured to logarithmic growth phase for the study.The U266 cells we
会议
Clonal heterogeneity and evolutional paths in multiple myeloma revealed by QM-FISH in single cell of
Background Clonal heterogeneity is a hallmark of many solid and hematologic malignancies.Clonal heterogeneity may foster clonal evolution and interfere personalized care strategies in multiple myeloma
会议
Deletion of CD27 Located at Chromosome 12p13.31 Detected by I-FISH is Associated with High Tumor Bur
Background The cytogenetic abnormalities are the most important prognostic factor and can be used to guide therapy decisions in multiple myeloma (MM).It has been currently recognized the negative impa
会议